Recapitulating the tumor ecosystem along the metastatic cascade using 3D culture models

Frontiers in Oncology

Volumn 5, Issue , 2015, Pages

  Kim, Jiyun ^a,b   Tanner, Kandice ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Seoul National University   (South Korea)

Author keywords

3D culture models; Biomaterials and nanotechnology; Ecology; Hydrogels; Tumor microenvironment

Indexed keywords

ANTIINFLAMMATORY ACTIVITY; BIOENGINEERING; CANCER MODEL; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; ECOSYSTEM; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HYDROGEL; HYPOXIA; METASTASIS; NONHUMAN; REVIEW; TOPOGRAPHY; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84983650170     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00170     Document Type: Review

References (266)

1. Wagle N, Emery C, Berger MF, Davis MJ, Sawyer A, Pochanard P, et al. Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J Clin Oncol (2011) 29(22):3085-96. doi:10.1200/JCO. 2010.33.2312
2. Colozza M, de Azambuja E, Personeni N, Lebrun F, Piccart MJ, Cardoso F. Achievements in systemic therapies in the pregenomic era in metastatic breast cancer. Oncologist (2007) 12(3):253-70. doi:10.1634/theoncologist.12-3-253
3. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov (2005) 4(12):988-1004. doi:10.1038/nrd1902
4. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature (2006) 439(7074):353-7. doi:10.1038/nature04296
5. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 366(10):883-92. doi:10.1056/NEJMoa1113205
6. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature (2012) 481(7382):506-10. doi:10.1038/nature10738
7. Mullighan CG, Phillips LA, Su X, Ma J, Miller CB, ShurtleffSA, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science (2008) 322(5906):1377-80. doi:10.1126/science.1164266
8. McGranahan N, Swanton C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell (2015) 27(1):15-26. doi:10.1016/j.ccell.2014.12.001
9. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer (2002) 2(8):563-72. doi:10.1038/nrc865
10. Bragado P, Estrada Y, Parikh F, Krause S, Capobianco C, Farina HG, et al. TGF-beta 2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38 alpha/beta signalling. Nat Cell Biol (2013) 15(11):1351-U1210. doi:10.1038/ncb2861
11. Malanchi I, Santamaria-Martínez A, Susanto E, Peng H, Lehr HA, Delaloye JF, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature (2012) 481(7379):85-95. doi:10.1038/nature10694
12. Barkan D, Green JE, Chambers AF. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer (2010) 46(7):1181-8. doi:10.1016/j.ejca.2010.02.027
13. Schewe DM, Aguirre-Ghiso JA. ATF6 alpha-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proc Natl Acad Sci U S A (2008) 105(30):10519-24. doi:10.1073/pnas.0800939105
14. Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, et al. Chromatin- modifying enzymes as modulators of reprogramming. Nature (2012) 483(7391):598-U119. doi:10.1038/nature10953
15. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature (2001) 414(6859):105-11. doi:10.1038/35102167
16. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature (2009) 458(7239):776-9. doi:10.1038/nature 07737
17. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature (2005) 434(7035):843-50. doi:10.1038/nature03319
18. Cairns J. The evolution of cancer research. Cancer Cells (1989) 1(1):1-8
19. Nowell PC. The clonal evolution of tumor cell populations. Science (1976) 194(4260):23-8. doi:10.1126/science.959840
20. Anderson AR, Weaver AM, Cummings PT, Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell (2006) 127(5):905-15. doi:10.1016/j.cell.2006.09.042
21. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and darwinian selection in tumours. Trends Cell Biol (1999) 9(12):M57-60. doi:10.1016/S0962-8924(99)01661-X
22. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature (2001) 411(6835):375-9. doi:10.1038/35077241
23. Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature (2013) 501(7467):328-37. doi:10.1038/nature12624
24. Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta (2010) 1805(1):105-17. doi:10.1016/j.bbcan.2009.11.002
25. Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res (2012) 72(19):4875-82. doi:10.1158/0008-5472.CAN-12-2217
26. O'Brien SJ. A role for molecular genetics in biological conservation. Proc Natl Acad Sci U S A (1994) 91(13):5748-55. doi:10.1073/pnas.91.13.5748
27. Lynch M, Conery J, Burger R. Mutation accumulation and the extinction of small populations. Am Nat (1995) 146(4):489-518. doi:10.1086/285812
28. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer (2001) 1(1):46-54. doi:10.1038/35094059
29. Villanueva J, Herlyn M. Melanoma and the tumor microenvironment. Curr Oncol Rep (2008) 10(5):439-46. doi:10.1007/s11912-008-0067-y
30. Kumar S, Weaver VM. Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev (2009) 28(1-2):113-27. doi:10.1007/s10555-008-9173-4
31. Swartz MA, Iida N, Roberts EW, Sangaletti S, Wong MH, Yull FE, et al. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res (2012) 72(10):2473-80. doi:10.1158/0008-5472.CAN-12-0122
32. Tanner K, Gottesman MM. Beyond 3D culture models of cancer. Sci Transl Med (2015) 7(283):283s9. doi:10.1126/scitranslmed.3009367
33. Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res (2000) 60(9):2497-503
34. Radisky D, Hagios C, Bissell MJ. Tumors are unique organs defined by abnormal signaling and context. Semin Cancer Biol (2001) 11(2):87-95. doi:10.1006/scbi.2000.0360
35. Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell (2010) 18(6):884-901. doi:10.1016/j.devcel.2010.05.012
36. Odum EP. Fundamentals of Ecology. Philadelphia, PA: Saunders (1953). 384 p
37. Pienta KJ, McGregor N, Axelrod R, Axelrod DE. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Transl Oncol (2008) 1(4):158-64. doi:10.1593/tlo.08178
38. Thomas F, Fisher D, Fort P, Marie JP, Daoust S, Roche B, et al. Applying ecological and evolutionary theory to cancer: a long and winding road. Evol Appl (2013) 6(1):1-10. doi:10.1111/eva.12021
39. Box C, Rogers SJ, Mendiola M, Eccles SA. Tumour-microenvironmental interactions: paths to progression and targets for treatment. Semin Cancer Biol (2010) 20(3):128-38. doi:10.1016/j.semcancer.2010.06.004
40. Jones CG, Lawton JH, Shachak M. Organisms as Ecosystem Engineers. Ecosystem Management. Springer (1996). p. 130-47
41. Odling-Smee FJ, Laland KN, Feldman MW. Niche Construction: The Neglected Process in Evolution. Princeton University Press (2003)
42. Lu PF, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol (2012) 196(4):395-406. doi:10.1083/jcb.201102147
43. O'Brien LE, Zegers MM, Mostov KE. Opinion: building epithelial architecture: insights from three-dimensional culture models. Nat Rev Mol Cell Biol (2002) 3(7):531-7. doi:10.1038/nrm859
44. Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell (2007) 130(4):601-10. doi:10.1016/j.cell.2007.08.006
45. Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods (2007) 4(4):359-65. doi:10.1038/nmeth1015
46. Kern J, Steurer M, Gastl G, Gunsilius E, Untergasser G. Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo. BMC Cancer (2009) 9:284. doi:10.1186/1471-2407-9-284
47. Yang F, Murugan R, Wang S, Ramakrishna S. Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials (2005) 26(15):2603-10. doi:10.1016/j. biomaterials.2004.06.051
48. Khademhosseini A, Langer R, Borenstein J, Vacanti JP. Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 103(8):2480-7. doi:10.1073/pnas.0507681102
49. Wellings SR, Jentoft VL. Organ cultures of normal, dysplastic, hyperplastic, and neoplastic human mammary tissues. J Natl Cancer Inst (1972) 49(2):329-38
50. Tanner K. Regulation of the basement membrane by epithelia generated forces. Phys Biol (2012) 9(6):065003. doi:10.1088/1478-3975/9/6/065003
51. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell (2010) 141(1):52-67. doi:10.1016/j. cell.2010.03.015
52. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med (1986) 315(26):1650-9. doi:10.1056/NEJM198612253152606
53. Dolberg DS, Hollingsworth R, Hertle M, Bissell MJ. Wounding and its role in RSV-mediated tumor formation. Science (1985) 230(4726):676-8. doi:10.1126/science.2996144
54. Martins-Green M, Boudreau N, Bissell MJ. Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res (1994) 54(16):4334-41
55. Coussens LM, Werb Z. Inflammation and cancer. Nature (2002) 420(6917):860-7. doi:10.1038/nature01322
56. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell (2006) 124(2):263-6. doi:10.1016/j. cell.2006.01.007
57. Pickup M, Novitskiy S, Moses HL. The roles of TGFbeta in the tumour microenvironment. Nat Rev Cancer (2013) 13(11):788-99. doi:10.1038/nrc3603
58. Provenzano PP, Inman DR, Eliceiri KW, Keely PJ. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene (2009) 28(49):4326-43. doi:10.1038/onc.2009.299
59. Nasser NJ. Heparanase involvement in physiology and disease. Cell Mol Life Sci (2008) 65(11):1706-15. doi:10.1007/s00018-008-7584-6
60. Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol (2006) 38(12):2018-39. doi:10.1016/j.biocel.2006.06.004
61. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci (2010) 123(24):4195-200. doi:10.1242/jcs.023820
62. Barker HE, Cox TR, Erler JT. The rationale for targeting the LOX family in cancer. Nat Rev Cancer (2012) 12(8):540-52. doi:10.1038/nrc3319
63. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell (2009) 139(5):891-906. doi:10.1016/j.cell.2009.10.027
64. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med (2006) 4(1):38. doi:10.1186/1741-7015-4-38
65. Radisky DC, Bissell MJ. Matrix metalloproteinase-induced genomic instability. Curr Opin Genet Dev (2006) 16(1):45-50. doi:10.1016/j.gde.2005.12.011
66. Pantel K, BrakenhoffRH. Dissecting the metastatic cascade. Nat Rev Cancer (2004) 4(6):448-56. doi:10.1038/nrc1370
67. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev (1989) 8(2):98-101
68. Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep (2014) 15(12):1243-53. doi:10.15252/embr.201439246
69. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol (2006) 1:119-50. doi:10.1146/annurev. pathol.1.110304.100224
70. DeCosse JJ, Gossens CL, Kuzma JF, Unsworth BR. Breast-cancer - induction of differentiation by embryonic tissue. Science (1973) 181(4104):1057-8. doi:10.1126/science.181.4104.71. Ingber DE, Madri JA, Jamieson JD. Basement-membrane as a spatial organizer of polarized epithelia - exogenous basement-membrane reorients pancreatic epithelial tumor-cells invitro. Am J Pathol (1986) 122(1):129-39
71. Ingber DE, Madri JA, Jamieson JD. Basement-membrane as a spatial organizer of polarized epithelia - exogenous basement-membrane reorients pancreatic epithelial tumor-cells invitro. Am J Pathol (1986) 122(1):129-39
72. Chung LW, Zhau HE, Ro JY. Morphologic and biochemical alterations in rat prostatic tumors induced by fetal urogenital sinus mesenchyme. Prostate (1990) 17(2):165-74. doi:10.1002/pros.2990170210
73. Maffini MV, Calabro JM, Soto AM, Sonnenschein C. Stromal regulation of neoplastic development - age-dependent normalization of neoplastic mammary cells by mammary stroma. Am J Pathol (2005) 167(5):1405-10. doi:10.1016/S0002-9440(10)61227-8
74. Ackerman A, Klein O, McDermott DF, Wang W, Ibrahim N, Lawrence DP, et al. Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors. Cancer (2014) 120(11):1695-701. doi:10.1002/cncr.28620
75. Kenny PA, Bissell MJ. Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer (2003) 107(5):688-95. doi:10.1002/ijc.11491
76. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res (2009) 69(6):2260-8. doi:10.1158/0008-5472.CAN-07-5575
77. Mintz B, Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A (1975) 72(9):3585-9. doi:10.1073/pnas.72.9.3585
78. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol (1997) 137(1):231-45. doi:10.1083/jcb.137.1.231
79. Braun AC. A demonstration of the recovery of the crown-gall tumor cell with the use of complex tumors of single-cell origin. Proc Natl Acad Sci U S A (1959) 45(7):932-8. doi:10.1073/pnas.45.7.932
80. Ingber DE. Can cancer be reversed by engineering the tumor microenvironment? Semin Cancer Biol (2008) 18(5):356-64. doi:10.1016/j.semcancer. 2008.03.016
81. Fisher MB, Mauck RL. Tissue engineering and regenerative medicine: recent innovations and the transition to translation. Tissue Eng Part B Rev (2013) 19(1):1-13. doi:10.1089/ten. TEB.2012.0723
82. Blehm BH, Jiang N, Kotobuki Y, Tanner K. Deconstructing the role of the ECM microenvironment on drug efficacy targeting MAPK signaling in a pre-clinical platform for cutaneous melanoma. Biomaterials (2015) 56:129-39. doi:10.1016/j.biomaterials.2015.03.041
83. Cukierman E, Pankov R, Yamada KM. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol (2002) 14(5):633-9. doi:10.1016/S0955-0674(02)00364-2
84. Kleinman HK, Martin GR. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol (2005) 15(5):378-86. doi:10.1016/j. semcancer.2005.05.004
85. Ulrich TA, Jain A, Tanner K, MacKay JL, Kumar S. Probing cellular mechanobiology in three-dimensional culture with collagen-agarose matrices. Biomaterials (2010) 31(7):1875-84. doi:10.1016/j.biomaterials.2009.10.047
86. Even-Ram S, Yamada KM. Cell migration in 3D matrix. Curr Opin Cell Biol (2005) 17(5):524-32. doi:10.1016/j.ceb.2005.08.015
87. Benton G, Kleinman HK, George J, Arnaoutova I. Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells. Int J Cancer (2011) 128(8):1751-7. doi:10.1002/ijc.25781
88. Beck JN, Singh A, Rothenberg AR, ElisseeffJH, Ewald AJ. The independent roles of mechanical, structural and adhesion characteristics of 3D hydrogels on the regulation of cancer invasion and dissemination. Biomaterials (2013) 34(37):9486-95. doi:10.1016/j.biomaterials.2013.08.077
89. Lovitt CJ, Shelper TB, Avery VM. Advanced cell culture techniques for cancer drug discovery. Biology (Basel) (2014) 3(2):345-67. doi:10.3390/biology3020345
90. Ashley N, Yeung TM, Bodmer WF. Stem cell differentiation and lumen formation in colorectal cancer cell lines and primary tumors. Cancer Res (2013) 73(18):5798-809. doi:10.1158/0008-5472.CAN-13-0454
91. Vega-Naredo I, Loureiro R, Mesquita KA, Barbosa IA, Tavares LC, Branco AF, et al. Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells. Cell Death Differ (2014) 21(10):1560-74. doi:10.1038/cdd.2014.66
92. Chen L, Xiao Z, Meng Y, Zhao Y, Han J, Su G, et al. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials (2012) 33(5):1437-44. doi:10.1016/j.biomaterials.2011.10.056
93. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A (2008) 105(36):13427-32. doi:10.1073/pnas.0805706105
94. Anastasov N, Höfig I, Radulovic V, Ströbel S, Salomon M, Lichtenberg J, et al. A 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatment. BMC Cancer (2015) 15:466. doi:10.1186/s12885-015-1481-9
95. Keung AJ, Kumar S, Schaffer DV. Presentation counts: microenvironmental regulation of stem cells by biophysical and material cues. Annu Rev Cell Dev Biol (2010) 26:533-56. doi:10.1146/annurev-cellbio-100109-104042
96. Levental I, Georges PC, Janmey PA. Soft biological materials and their impact on cell function. Soft Matter (2007) 3(3):299-306. doi:10.1039/B610522J
97. Schwartz MP, Fairbanks BD, Rogers RE, Rangarajan R, Zaman MH, Anseth KS. A synthetic strategy for mimicking the extracellular matrix provides new insight about tumor cell migration. Integr Biol (Camb) (2010) 2(1):32-40. doi:10.1039/b912438a
98. Lutolf MP, Lauer-Fields JL, Schmoekel HG, Metters AT, Weber FE, Fields GB, et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci U S A (2003) 100(9):5413-8. doi:10.1073/pnas.0737381100
99. Raeber GP, Lutolf MP, Hubbell JA. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J (2005) 89(2):1374-88. doi:10.1529/biophysj.104.050682
100. Na K, Park KH, Kim SW, Bae YH. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2). J Control Release (2000) 69(2):225-36. doi:10.1016/S0168-3659(00)00256-X
101. Roy R, Boskey A, Bonassar LJ. Processing of type I collagen gels using nonenzymatic glycation. J Biomed Mater Res A (2010) 93a(3):843-51. doi:10.1002/jbm.a.32231
102. Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature (2013) 501(7467):346-54. doi:10.1038/nature12626
103. Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol (2013) 14(10):1014-22. doi:10.1038/ni.2703
104. Mao Y, Keller ET, Garfield DH, Shen K, Wang J. Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev (2013) 32(1-2): 303-15. doi:10.1007/s10555-012-9415-3
105. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med (2013) 19(11):1423-37. doi:10.1038/nm.3394
106. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell (2010) 140(6):883-99. doi:10.1016/j.cell.2010.01.025
107. De Palma M, Naldini L. Tie2-expressing monocytes (TEMs): novel targets and vehicles of anticancer therapy? Biochim Biophys Acta (2009) 1796(1):5-10. doi:10.1016/j.bbcan.2009.04.001
108. Khazaie K, Blatner NR, Khan MW, Gounari F, Gounaris E, Dennis K, et al. The significant role of mast cells in cancer. Cancer Metastasis Rev (2011) 30(1):45-60. doi:10.1007/s10555-011-9286-z
109. Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer (2008) 8(8):618-31. doi:10.1038/nrc2444
110. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol (2012) 12(4):253-68. doi:10.1038/nri3175
111. de Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell (2005) 7(5):411-23. doi:10.1016/j.ccr.2005.04.014
112. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol (2008) 9(5):503-10. doi:10.1038/ni1582
113. Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 12(4):265-77. doi:10.1038/nrc3258
114. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol (2011) 11(8):519-31. doi:10.1038/nri3024
115. Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology (2013) 138(2):105-15. doi:10.1111/imm.12036
116. von Boehmer H, Daniel C. Therapeutic opportunities for manipulating T-Reg cells in autoimmunity and cancer. Nat Rev Drug Discov (2013) 12(1):51-63. doi:10.1038/nrd3683
117. Qian X, Wang X, Jin H. Cell transfer therapy for cancer: past, present, and future. J Immunol Res (2014) 2014:525913. doi:10.1155/2014/525913118. Lotze MT, Matory YL, Rayner AA, Ettinghausen SE, Vetto JT, Seipp CA, et al. Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer (1986) 58(12):2764-72
118. Lotze MT, Matory YL, Rayner AA, Ettinghausen SE, Vetto JT, Seipp CA, et al. Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer (1986) 58(12):2764-72
119. Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood (2005) 105(8):3051-7. doi:10.1182/blood-2004-07-2974
120. Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nat Rev Cancer (2012) 12(4):278-87. doi:10.1038/nrc3236
121. Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol (2012) 12(4):269-81. doi:10.1038/nri3191
122. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer (2006) 6(5): 392-401. doi:10.1038/nrc1877
123. Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth - bystanders turning into key players. Curr Opin Genet Dev (2009) 19(1):67-73. doi:10.1016/j.gde.2009.01.003
124. Ohlund D, Elyada E, Tuveson D. Fibroblast heterogeneity in the cancer wound. J Exp Med (2014) 211(8):1503-23. doi:10.1084/jem.20140692
125. Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res (2006) 66(2):632-7. doi:10.1158/0008-5472.CAN-05-3260
126. Basanta D, Scott JG, Fishman MN, Ayala G, Hayward SW, Anderson AR. Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game. Br J Cancer (2012) 106(1):174-81. doi:10.1038/bjc.2011.517
127. Franco OE, Shaw AK, Strand DW, Hayward SW. Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol (2010) 21(1):33-9. doi:10.1016/j. semcdb.2009.10.010
128. Capparelli C, Chiavarina B, Whitaker-Menezes D, Pestell TG, Pestell RG, Hulit J, et al. CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, "fueling" tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle (2012) 11(19):3599-610. doi:10.4161/cc.21884
129. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer (2003) 3(6):401-10. doi:10.1038/nrc1093
130. Zerbini G, Lorenzi M, Palini A. Tumor angiogenesis. N Engl J Med (2008) 359(7):763-763. doi:10.1056/NEJMc081278
131. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 86(3):353-64. doi:10.1016/S0092-8674(00)80108-7
132. Tan JX, Buache E, Chenard MP, Dali-Youcef N, Rio MC. Adipocyte is a non-trivial, dynamic partner of breast cancer cells. Int J Dev Biol (2011) 55(7-9):851-9. doi:10.1387/ijdb.113365jt
133. Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, et al. Cancer- associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res (2011) 71(7):2455-65. doi:10.1158/0008-5472. CAN-10-3323
134. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer (2007) 7(10):763-77. doi:10.1038/nrc2222
135. Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell (2010) 140(1):49-61. doi:10.1016/j.cell.2009.11.027
136. Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F. Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther (2010) 9(5):1092-9. doi:10.1158/1535-7163.MCT-09-1186
137. Mancino M, Ametller E, Gascon P, Almendro V. The neuronal influence on tumor progression. Biochim Biophys Acta (2011) 1816(2):105-18. doi:10.1016/j.bbcan.2011.04.005
138. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer (2009) 115(15):3379-91
139. Jimenez-Andrade JM, Bloom AP, Stake JI, Mantyh WG, Taylor RN, Freeman KT, et al. Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J Neurosci (2010) 30(44):14649-56. doi:10.1523/JNEUROSCI.3300-10.2010
140. Hoffmann TK, Schirlau K, Sonkoly E, Brandau S, Lang S, Pivarcsi A, et al. A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration. Int J Cancer (2009) 124(11):2589-96. doi:10.1002/ijc.24269
141. Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol (2013) 15(7):807-17. doi:10.1038/ncb2767
142. Krause S, Maffini MV, Soto AM, Sonnenschein C. A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland. Tissue Eng Part C Methods (2008) 14(3):261-71. doi:10.1089/ten.tec.2008.0030
143. Yang CC, Burg KJ. Designing a tunable 3D heterocellular breast cancer tissue test system. J Tissue Eng Regen Med (2015) 9(3):310-4. doi:10.1002/term.1660
144. Derda R, Laromaine A, Mammoto A, Tang SK, Mammoto T, Ingber DE, et al. Paper-supported 3D cell culture for tissue-based bioassays. Proc Natl Acad Sci U S A (2009) 106(44):18457-62. doi:10.1073/pnas.0910666106
145. Derda R, Tang SK, Laromaine A, Mosadegh B, Hong E, Mwangi M, et al. Multizone paper platform for 3D cell cultures. PLoS One (2011) 6(5):e18940. doi:10.1371/journal.pone.0018940
146. Sakaguchi K, Shimizu T, Horaguchi S, Sekine H, Yamato M, Umezu M, et al. In vitro engineering of vascularized tissue surrogates. Sci Rep (2013) 3:1316. doi:10.1038/srep01316
147. Kang YB, Rawat S, Cirillo J, Bouchard M, Noh HM. Layered long-term co-culture of hepatocytes and endothelial cells on a transwell membrane: toward engineering the liver sinusoid. Biofabrication (2013) 5(4):045008. doi:10.1088/1758-5082/5/4/045008
148. Carrion B, Huang CP, Ghajar CM, Kachgal S, Kniazeva E, Jeon NL, et al. Recreating the perivascular niche ex vivo using a microfluidic approach. Biotechnol Bioeng (2010) 107(6):1020-8. doi:10.1002/bit.22891
149. Kim JB, Stein R, O'Hare MJ. Three-dimensional in vitro tissue culture models of breast cancer - a review. Breast Cancer Res Treat (2004) 85(3):281-91. doi:10.1023/B:BREA.0000025418.88785.2b
150. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol (2010) 148(1):3-15. doi:10.1016/j.jbiotec. 2010.01.012
151. Kross KW, Heimdal JH, Olsnes C, Olofsson J, Aarstad HJ. Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis. Scand J Immunol (2008) 67(4):392-9. doi:10.1111/j.1365-3083.2008.02072.x
152. Slater SC, Beachley V, Hayes T, Zhang D, Welsh GI, Saleem MA, et al. An in vitro model of the glomerular capillary wall using electrospun collagen nanofibres in a bioartificial composite basement membrane. PLoS One (2011) 6(6):e20802. doi:10.1371/journal.pone.0020802
153. Moraes C, Mehta G, Lesher-Perez SC, Takayama S. Organs-on-a-chip: a focus on compartmentalized microdevices. Ann Biomed Eng (2012) 40(6):1211-27. doi:10.1007/s10439-011-0455-6
154. Byun CK, Hwang H, Choi WS, Yaguchi T, Park J, Kim D, et al. Productive chemical interaction between a bacterial microcolony couple is enhanced by periodic relocation. J Am Chem Soc (2013) 135(6):2242-7. doi:10.1021/ja3094923
155. Nikkhah M, Strobl JS, Schmelz EM, Roberts PC, Zhou H, Agah M. MCF10A and MDA-MB-231 human breast basal epithelial cell co-culture in silicon micro-arrays. Biomaterials (2011) 32(30):7625-32. doi:10.1016/j. biomaterials.2011.06.041
156. Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science (2010) 328(5986):1662-8. doi:10.1126/science.1188302
157. Ebrahimkhani MR, Neiman JA, Raredon MS, Hughes DJ, Griffith LG. Bioreactor technologies to support liver function in vitro. Adv Drug Deliv Rev (2014) 6(9-70):132-57. doi:10.1016/j.addr.2014.02.011
158. Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature (2013) 501(7467):373-9. doi:10.1038/nature12517
159. Sato T, Clevers H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science (2013) 340(6137):1190-4. doi:10.1126/science.1234852
160. Kim HJ, Boedicker JQ, Choi JW, Ismagilov RF. Defined spatial structure stabilizes a synthetic multispecies bacterial community. Proc Natl Acad Sci U S A (2008) 105(47):18188-93. doi:10.1073/pnas.0807935105
161. van der Meer AD, Orlova VV, ten Dijke P, van den Berg A, Mummery CL. Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device. Lab Chip (2013) 13(18):3562-8. doi:10.1039/c3lc50435b
162. Sounni NE, Noel A. Targeting the tumor microenvironment for cancer therapy. Clin Chem (2013) 59(1):85-93. doi:10.1373/clinchem.2012.185363
163. Mierke CT. The fundamental role of mechanical properties in the progression of cancer disease and inflammation. Rep Prog Phys (2014) 77(7):076602. doi:10.1088/0034-4885/77/7/076602
164. Wojtkowiak JW, Verduzco D, Schramm KJ, Gillies RJ. Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharm (2011) 8(6):2032-8. doi:10.1021/mp200292c
165. Roussos ET, Condeelis JS, Patsialou A. Chemotaxis in cancer. Nat Rev Cancer (2011) 11(8):573-87. doi:10.1038/nrc3078
166. Chung S, Sudo R, Mack PJ, Wan CR, Vickerman V, Kamm RD. Cell migration into scaffolds under co-culture conditions in a microfluidic platform. Lab Chip (2009) 9(2):269-75. doi:10.1039/b807585a
167. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer (2004) 4(6):437-47. doi:10.1038/nrc1367
168. Dudley AC. Tumor endothelial cells. Cold Spring Harb Perspect Med (2012) 2(3):a006536. doi:10.1101/cshperspect.a006536
169. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer (2002) 2(1):38-47. doi:10.1038/nrc704
170. Khacho M, Tarabay M, Patten D, Khacho P, MacLaurin JG, Guadagno J, et al. Acidosis overrides oxygen deprivation to maintain mitochondrial function and cell survival. Nat Commun (2014) 5:3550. doi:10.1038/ncomms4550
171. Chiche J, Brahimi-Horn MC, Pouyssegur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med (2010) 14(4):771-94. doi:10.1111/j.1582-4934.2009.00994.x
172. Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin Cancer Res (2002) 8(4):1284-91
173. Vaupel P, Fortmeyer HP, Runkel S, Kallinowski F. Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats. Cancer Res (1987) 47(13):3496-503
174. Kallinowski F, Schlenger KH, Runkel S, Kloes M, Stohrer M, OkunieffP, et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res (1989) 49(14):3759-64
175. Swaminathan V, Mythreye K, O'Brien ET, Berchuck A, Blobe GC, Superfine R. Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines. Cancer Res (2011) 71(15):5075-80. doi:10.1158/0008-5472.CAN-11-0247
176. Mouw JK, Yui Y, Damiano L, Bainer RO, Lakins JN, Acerbi I, et al. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat Med (2014) 20(4):360-7. doi:10.1038/nm.3497
177. Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol (2002) 15(5):502-16. doi:10.1038/modpathol.3880555
178. Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, et al. Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res (2010) 70(14):5706-16. doi:10.1158/0008-5472. CAN-09-2356
179. Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer (2011) 11(6):393-410. doi:10.1038/nrc3064
180. Nyga A, Cheema U, Loizidou M. 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal (2011) 5(3):239-48. doi:10.1007/s12079-011-0132-4
181. Shin Y, Jeon JS, Han S, Jung GS, Shin S, Lee SH, et al. In vitro 3D collective sprouting angiogenesis under orchestrated ANG-1 and VEGF gradients. Lab Chip (2011) 11(13):2175-81. doi:10.1039/c1lc20039a
182. Chung S, Sudo R, Zervantonakis IK, Rimchala T, Kamm RD. Surface- treatment-induced three-dimensional capillary morphogenesis in a microfluidic platform. Adv Mater (2009) 21(47):4863-7. doi:10.1002/adma.200901727
183. Sudo R, Chung S, Zervantonakis IK, Vickerman V, Toshimitsu Y, Griffith LG, et al. Transport-mediated angiogenesis in 3D epithelial coculture. FASEB J (2009) 23(7):2155-64. doi:10.1096/fj.08-122820
184. Jeon JS, Zervantonakis IK, Chung S, Kamm RD, Charest JL. In vitro model of tumor cell extravasation. PLoS One (2013) 8(2):e56910. doi:10.1371/journal. pone.0056910
185. Jeong GS, Han S, Shin Y, Kwon GH, Kamm RD, Lee SH, et al. Sprouting angiogenesis under a chemical gradient regulated by interactions with an endothelial monolayer in a microfluidic platform. Anal Chem (2011) 83(22):8454-9. doi:10.1021/ac202170e
186. Chung S, Sudo R, Vickerman V, Zervantonakis IK, Kamm RD. Microfluidic platforms for studies of angiogenesis, cell migration, and cell-cell interactions. Sixth international bio-fluid mechanics symposium and workshop March 28-30, 2008 Pasadena, California. Ann Biomed Eng (2010) 38(3):1164-77. doi:10.1007/s10439-010-9899-3
187. Jeong GS, Kwon GH, Kang AR, Jung BY, Park Y, Chung S, et al. Microfluidic assay of endothelial cell migration in 3D interpenetrating polymer semi-network HA-Collagen hydrogel. Biomed Microdevices (2011) 13(4):717-23. doi:10.1007/s10544-011-9541-7
188. Shin Y, Kim H, Han S, Won J, Jeong HE, Lee ES, et al. Extracellular matrix heterogeneity regulates three-dimensional morphologies of breast adenocarcinoma cell invasion. Adv Healthc Mater (2013) 2(6):790-4. doi:10.1002/adhm.201200320
189. Bersini S, Jeon JS, Dubini G, Arrigoni C, Chung S, Charest JL, et al. A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. Biomaterials (2014) 35(8):2454-61. doi:10.1016/j.biomaterials.2013.11.050
190. Rizvi I, Gurkan UA, Tasoglu S, Alagic N, Celli JP, Mensah LB, et al. Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules. Proc Natl Acad Sci U S A (2013) 110(22):E1974-83. doi:10.1073/pnas.1216989110
191. Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol (2014) 32(8):760-72. doi:10.1038/nbt.2989
192. Ingram M, Techy GB, Ward BR, Imam SA, Atkinson R, Ho H, et al. Tissue engineered tumor models. Biotech Histochem (2010) 85(4):213-29. doi:10.31 09/10520295.2010.483655
193. Li XJ, Valadez AV, Zuo P, Nie Z. Microfluidic 3D cell culture: potential application for tissue-based bioassays. Bioanalysis (2012) 4(12):1509-25. doi:10.4155/bio.12.133
194. Xu Z, Gao Y, Hao Y, Li E, Wang Y, Zhang J, et al. Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials (2013) 34(16):4109-17. doi:10.1016/j. biomaterials.2013.02.045
195. Hwang H, Park J, Shin C, Do Y, Cho YK. Three dimensional multicellular co-cultures and anti-cancer drug assays in rapid prototyped multilevel microfluidic devices. Biomed Microdevices (2013) 15(4):627-34. doi:10.1007/s10544-012-9733-9
196. Fischbach C, Kong HJ, Hsiong SX, Evangelista MB, Yuen W, Mooney DJ. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A (2009) 106(2):399-404. doi:10.1073/pnas.0808932106
197. Marushima H, Shibata S, Asakura T, Matsuura T, Maehashi H, Ishii Y, et al. Three-dimensional culture promotes reconstitution of the tumor-specific hypoxic microenvironment under TGFbeta stimulation. Int J Oncol (2011) 39(5):1327-36. doi:10.3892/ijo.2011.1142
198. DelNero P, Lane M, Verbridge SS, Kwee B, Kermani P, Hempstead B, et al. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways. Biomaterials (2015) 55:110-8. doi:10.1016/j. biomaterials.2015.03.035
199. Kim JW, Ho WJ, Wu BM. The role of the 3D environment in hypoxia-induced drug and apoptosis resistance. Anticancer Res (2011) 31(10):3237-45
200. Infanger DW, Lynch ME, Fischbach C. Engineered culture models for studies of tumor-microenvironment interactions. Annu Rev Biomed Eng (2013) 15:29-53. doi:10.1146/annurev-bioeng-071811-150028
201. Ma H, Xu H, Qin J. Biomimetic tumor microenvironment on a microfluidic platform. Biomicrofluidics (2013) 7(1):11501. doi:10.1063/1.4774070
202. Young EW. Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment. Integr Biol (Camb) (2013) 5(9):1096-109. doi:10.1039/c3ib40076j
203. Wagner I, Materne EM, Brincker S, Süssbier U, Frädrich C, Busek M, et al. A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. Lab Chip (2013) 13(18):3538-47. doi:10.1039/c3lc50234a
204. Haessler U, Kalinin Y, Swartz MA, Wu MW. An agarose-based microfluidic platform with a gradient buffer for 3D chemotaxis studies. Biomed Microdevices (2009) 11(4):827-35. doi:10.1007/s10544-009-9299-3
205. Lee PJ, Hung PJ, Lee LP. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol Bioeng (2007) 97(5):1340-6. doi:10.1002/bit.21360
206. Esch MB, Sung JH, Yang J, Yu C, Yu J, March JC, et al. On chip porous polymer membranes for integration of gastrointestinal tract epithelium with microfluidic 'body-on-a-chip' devices. Biomed Microdevices (2012) 14(5):895-906. doi:10.1007/s10544-012-9669-0
207. Kim HJ, Huh D, Hamilton G, Ingber DE. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip (2012) 12(12):2165-74. doi:10.1039/c2lc40074j
208. Cimetta E, Cannizzaro C, James R, Biechele T, Moon RT, Elvassore N, et al. Microfluidic device generating stable concentration gradients for long term cell culture: application to Wnt3a regulation of beta-catenin signaling. Lab Chip (2010) 10(23):3277-83. doi:10.1039/c0lc00033g
209. Shin Y, Yang K, Han S, Park HJ, Seok Heo Y, Cho SW, et al. Reconstituting vascular microenvironment of neural stem cell niche in three-dimensional extracellular matrix. Adv Healthc Mater (2014) 3(9):1457-64. doi:10.1002/adhm.201300569
210. Han S, Yang K, Shin Y, Lee JS, Kamm RD, Chung S, et al. Three-dimensional extracellular matrix-mediated neural stem cell differentiation in a microfluidic device. Lab Chip (2012) 12(13):2305-8. doi:10.1039/c2lc21285d
211. DelNero P, Song YH, Fischbach C. Microengineered tumor models: insights & opportunities from a physical sciences-oncology perspective. Biomed Microdevices (2013) 15(4):583-93. doi:10.1007/s10544-013-9763-y
212. Ghaemmaghami AM, Hancock MJ, Harrington H, Kaji H, Khademhosseini A. Biomimetic tissues on a chip for drug discovery. Drug Discov Today (2012) 17(3-4):173-81. doi:10.1016/j.drudis.2011.10.029
213. Huh D, Hamilton GA, Ingber DE. From 3D cell culture to organs-on-chips. Trends Cell Biol (2011) 21(12):745-54. doi:10.1016/j.tcb.2011.09.005
214. Park SH, Sim WY, Min BH, Yang SS, Khademhosseini A, Kaplan DL. Chip- based comparison of the osteogenesis of human bone marrow- and adipose tissue-derived mesenchymal stem cells under mechanical stimulation. PLoS One (2012) 7(9):e46689. doi:10.1371/journal.pone.0046689
215. Horch RE, Boos AM, Quan Y, Bleiziffer O, Detsch R, Boccaccini AR, et al. Cancer research by means of tissue engineering - is there a rationale? J Cell Mol Med (2013) 17(10):1197-206. doi:10.1111/jcmm.12130
216. Garraway LA, Janne PA. Circumventing cancer drug resistance in the era of personalized medicine. Cancer Discov (2012) 2(3):214-26. doi:10.1158/2159-8290.CD-12-0012
217. Gordon RR, Nelson PS. Cellular senescence and cancer chemotherapy resistance. Drug Resist Updat (2012) 15(1-2):123-31. doi:10.1016/j.drup. 2012.01.002
218. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science (2011) 331(6024):1559-64. doi:10.1126/science.1203543
219. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 147(2):275-92. doi:10.1016/j.cell.2011.09.024
220. Physical Sciences - Oncology Centers Network, Agus DB, Alexander JF, Arap W, Ashili S, Aslan JE, et al. A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 3:1449. doi:10.1038/srep01449
221. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells (vol 146, pg 633, 2011). Cell (2011) 147(5):1197-1197. doi:10.1016/j.cell.2011.07.026
222. Findlay VJ, Wang C, Watson DK, Camp ER. Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer. Cancer Gene Ther (2014) 21(5):181-7. doi:10.1038/cgt.2014.15
223. Friedl P, Locker J, Sahai E, Segall JE. Classifying collective cancer cell invasion. Nat Cell Biol (2012) 14(8):777-83. doi:10.1038/ncb2548
224. Balaban RS, Hampshire VA. Challenges in small animal noninvasive imaging. ILAR J (2001) 42(3):248-62. doi:10.1093/ilar.42.3.248
225. Zhang X, Lin Y, Gillies RJ. Tumor pH and its measurement. J Nucl Med (2010) 51(8):1167-70. doi:10.2967/jnumed.109.068981
226. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 348(25):2491-9. doi:10.1056/NEJMoa022749
227. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - meta-analysis. Radiology (2005) 237(1):123-31. doi:10.1148/radiol.2371042060
228. Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med (2008) 14(4):459-65. doi:10.1038/nm1700
229. Serres S, Soto MS, Hamilton A, McAteer MA, Carbonell WS, Robson MD, et al. Molecular MRI enables early and sensitive detection of brain metastases. Proc Natl Acad Sci U S A (2012) 109(17):6674-9. doi:10.1073/pnas. 1117412109
230. Frese KK, Tuveson DA. Maximizing mouse cancer models. Nat Rev Cancer (2007) 7(9):645-58. doi:10.1038/nrc2192
231. Germain RN, Miller MJ, Dustin ML, Nussenzweig MC. Dynamic imaging of the immune system: progress, pitfalls and promise. Nat Rev Immunol (2006) 6(7):497-507. doi:10.1038/nri1884
232. Cahalan MD, Parker I, Wei SH, Miller MJ. Two-photon tissue imaging: seeing the immune system in a fresh light. Nat Rev Immunol (2002) 2(11):872-80. doi:10.1038/nri935
233. Rueckel M, Mack-Bucher JA, Denk W. Adaptive wavefront correction in two-photon microscopy using coherence-gated wavefront sensing. Proc Natl Acad Sci U S A (2006) 103(46):17137-42. doi:10.1073/pnas.0604791103
234. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer (2003) 3(12):921-30. doi:10.1038/nrc1231
235. Helmchen F, Denk W. Deep tissue two-photon microscopy. Nat Methods (2005) 2(12):932-40. doi:10.1038/nmeth818
236. WyckoffJB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res (2007) 67(6):2649-56. doi:10.1158/0008-5472.CAN-06-1823
237. Alexander S, Weigelin B, Winkler F, Friedl P. Preclinical intravital microscopy of the tumour-stroma interface: invasion, metastasis, and therapy response. Curr Opin Cell Biol (2013) 25(5):659-71. doi:10.1016/j.ceb.2013.07.001
238. Tanner K, Mori H, Mroue R, Bruni-Cardoso A, Bissell MJ. Coherent angular motion in the establishment of multicellular architecture of glandular tissues. Proc Natl Acad Sci U S A (2012) 109(6):1973-8. doi:10.1073/pnas.1119578109
239. Wong AD, Searson PC. Live-cell imaging of invasion and intravasation in an artificial microvessel platform. Cancer Res (2014) 74(17):4937-45. doi:10.1158/0008-5472.CAN-14-1042
240. Chen MB, Whisler JA, Jeon JS, Kamm RD. Mechanisms of tumor cell extravasation in an in vitro microvascular network platform. Integr Biol (Camb) (2013) 5(10):1262-71. doi:10.1039/c3ib40149a
241. Zervantonakis IK, Hughes-Alford SK, Charest JL, Condeelis JS, Gertler FB, Kamm RD. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc Natl Acad Sci U S A (2012) 109(34):13515-20. doi:10.1073/pnas.1210182109
242. Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell (2008) 132(3):487-98. doi:10.1016/j.cell.2007.12.033
243. Hoffman RM. In vivo cell biology of cancer cells visualized with fluorescent proteins. Curr Top Dev Biol (2005) 70:121-44. doi:10.1016/S0070-2153(05) 70006-5
244. Yu H, Mouw JK, Weaver VM. Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol (2011) 21(1):47-56. doi:10.1016/j.tcb.2010.08.015
245. Plodinec M, Loparic M, Monnier CA, Obermann EC, Zanetti-Dallenbach R, Oertle P, et al. The nanomechanical signature of breast cancer. Nat Nanotechnol (2012) 7(11):757-65. doi:10.1038/nnano.2012.167
246. Legant WR, Choi CK, Miller JS, Shao L, Gao L, Betzig E, et al. Multidimensional traction force microscopy reveals out-of-plane rotational moments about focal adhesions. Proc Natl Acad Sci U S A (2013) 110(3):881-6. doi:10.1073/pnas. 1207997110
247. Gardel ML, Kasza KE, Brangwynne CP, Liu J, Weitz DA. Chapter 19: Mechanical response of cytoskeletal networks. Methods Cell Biol (2008) 89: 487-519. doi:10.1016/S0091-679X(08)00619-5
248. Blehm BH, Schroer TA, Trybus KM, Chemla YR, Selvin PR. In vivo optical trapping indicates kinesin's stall force is reduced by dynein during intracellular transport. Proc Natl Acad Sci U S A (2013) 110(9):3381-6. doi:10.1073/pnas.1219961110
249. Korolev KS, Xavier JB, Gore J. Turning ecology and evolution against cancer. Nat Rev Cancer (2014) 14(5):371-80. doi:10.1073/pnas.1219961110
250. Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer (2014) 14(9):611-22. doi:10.1038/nrc3793
251. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell (2008) 13(1):58-68. doi:10.1016/j.ccr.2007.12.003
252. Scheffer M, Carpenter SR, Lenton TM, Bascompte J, Brock W, Dakos V, et al. Anticipating critical transitions. Science (2012) 338(6105):344-8. doi:10.1126/science.1225244
253. van Nes EH, Scheffer M. Implications of spatial heterogeneity for catastrophic regime shifts in ecosystems. Ecology (2005) 86(7):1797-807. doi:10.1890/04-0550
254. Dunne JA, Williams RJ, Martinez ND. Network structure and biodiversity loss in food webs: robustness increases with connectance. Ecol Lett (2002) 5(4):558-67. doi:10.1371/journal.pbio.1001579
255. Katz E, Dubois-Marshall S, Sims AH, Gautier P, Caldwell H, Meehan RR, et al. An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer. PLoS One (2011) 6(2):e17083. doi:10.1371/journal.pone.0017083
256. Li Q, Chen C, Kapadia A, Zhou Q, Harper MK, Schaack J, et al. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen. J Biomol Screen (2011) 16(2):141-54. doi:10.1177/1087057110392995
257. Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, Santos V, et al. The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc (2009) 4(11):1591-613. doi:10.1038/nprot.2009.152
258. Ben-Jacob E, Coffey DS, Levine H. Bacterial survival strategies suggest rethinking cancer cooperativity. Trends Microbiol (2012) 20(9):403-10. doi:10.1016/j.tim.2012.06.001
259. Liu X, Johnson S, Liu S, Kanojia D, Yue W, Singh UP, et al. Nonlinear growth kinetics of breast cancer stem cells: implications for cancer stem cell targeted therapy. Sci Rep (2013) 3:2473. doi:10.1038/srep02473
260. Sprouffske K, Pepper JW, Maley CC. Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev Res (Phila) (2011) 4(7):1135-44. doi:10.1158/1940-6207.CAPR-10-0374
261. Attolini CS, Cheng YK, Beroukhim R, Getz G, Abdel-Wahab O, Levine RL, et al. A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc Natl Acad Sci U S A (2010) 107(41): 17604-9. doi:10.1073/pnas.1009117107
262. Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, Sawyers CL, et al. Dynamics of chronic myeloid leukaemia. Nature (2005) 435(7046):1267-70. doi:10.1038/nature03669
263. Bozic I, Reiter JG, Allen B, Antal T, Chatterjee K, Shah P, et al. Evolutionary dynamics of cancer in response to targeted combination therapy. Elife (2013) 2:e00747. doi:10.7554/eLife.00747
264. Cunningham JJ, Gatenby RA, Brown JS. Evolutionary dynamics in cancer therapy. Mol Pharm (2011) 8(6):2094-100. doi:10.1021/mp2002279
265. Frieboes HB, Zheng X, Sun CH, Tromberg B, Gatenby R, Cristini V. An integrated computational/experimental model of tumor invasion. Cancer Res (2006) 66(3):1597-604. doi:10.1158/0008-5472.CAN-05-3166
266. Frieboes HB, Edgerton ME, Fruehauf JP, Rose FR, Worrall LK, Gatenby RA, et al. Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res (2009) 69(10):4484-92. doi:10.1158/0008-5472.CAN-08-3740